BIOMARKER FOR DIAGNOSSIS OF BILIARY TRACT CANCER USING TARGET GENES OF MICRO RNA
Disclosed is a biomarker for diagnosis of a biliary tract cancer. The biomarker includes ACSM5, ADH6, ALDH1L1, APOA5, BHMT, CCL16, CYP1A2, CYP3A43, DAO, DDC, ESR1, F11, F13B, FETUB, GLYAT, GNMT, IGFALS, NAT2, PFKFB1, RDH16, SRD5A2, SULT2A1, and THRSP.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Korean |
Published |
27.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed is a biomarker for diagnosis of a biliary tract cancer. The biomarker includes ACSM5, ADH6, ALDH1L1, APOA5, BHMT, CCL16, CYP1A2, CYP3A43, DAO, DDC, ESR1, F11, F13B, FETUB, GLYAT, GNMT, IGFALS, NAT2, PFKFB1, RDH16, SRD5A2, SULT2A1, and THRSP. |
---|---|
Bibliography: | Application Number: KR20130042328 |